Oncology Research
Innovative clinical trials focusing on breast cancer treatments, including studies of ribociclib with endocrine therapy for HR-positive, HER2-negative cases. Additional research encompasses various blood cancers, including lymphomas and leukemia.
- Early-stage breast cancer therapy
- Diffuse large B-cell lymphoma treatments
- Acute myeloid leukemia management
Cutting-edge research evaluating novel therapeutic combinations and treatment approaches for better patient outcomes.
Dermatological Studies
Comprehensive research into chronic skin conditions, including trials for plaque psoriasis and atopic dermatitis. Studies evaluate new therapeutic agents for moderate to severe cases.
- Hidradenitis suppurativa treatments
- Novel psoriasis therapies
- Atopic dermatitis management
Focus on developing effective treatments for persistent skin conditions that significantly impact quality of life.
Gastrointestinal Research
Advanced studies in inflammatory bowel diseases, particularly Crohn’s disease and ulcerative colitis. Trials investigate innovative therapies for moderate to severe cases.
- Long-term disease management
- Combination therapy approaches
- Treatment-resistant cases
Investigation of new therapeutic options for patients with inadequate response to conventional treatments.
